Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Arguments for live flavivirus vaccines.

× No keyword cloud information.

9 in total

Review 1. The tortoise or the hare? Impacts of within-host dynamics on transmission success of arthropod-borne viruses.

Authors: Benjamin M Althouse; Kathryn A Hanley
Journal: Philos Trans R Soc Lond B Biol Sci Date: 2015-08-19 Impact factor: 6.237

2. Size heterogeneity in the 3' noncoding region of South American isolates of yellow fever virus.

Authors: Juliet E Bryant; Pedro F C Vasconcelos; Rene C A Rijnbrand; J P Mutebi; Stephen Higgs; Alan D T Barrett
Journal: J Virol Date: 2005-03 Impact factor: 5.103

3. Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys.

Authors: Joseph E Blaney; Jennifer M Matro; Brian R Murphy; Stephen S Whitehead
Journal: J Virol Date: 2005-05 Impact factor: 5.103

4. West Nile virus (WNV) genome RNAs with up to three adjacent mutations that disrupt long distance 5'-3' cyclization sequence basepairs are viable.

Authors: Mausumi Basu; Margo A Brinton
Journal: Virology Date: 2011-02-02 Impact factor: 3.616

5. A tetravalent dengue vaccine based on a complex adenovirus vector provides significant protection in rhesus monkeys against all four serotypes of dengue virus.

Authors: Kanakatte Raviprakash; Danher Wang; Dan Ewing; David H Holman; Karla Block; Jan Woraratanadharm; Lan Chen; Curtis Hayes; John Y Dong; Kevin Porter
Journal: J Virol Date: 2008-05-14 Impact factor: 5.103

6. Substitution of wild-type yellow fever Asibi sequences for 17D vaccine sequences in ChimeriVax-dengue 4 does not enhance infection of Aedes aegypti mosquitoes.

Authors: Charles E McGee; Konstantin Tsetsarkin; Dana L Vanlandingham; Kate L McElroy; Jean Lang; Bruno Guy; Thierry Decelle; Stephen Higgs
Journal: J Infect Dis Date: 2008-03-01 Impact factor: 5.226

Arguments for live flavivirus vaccines.

Review 1. The tortoise or the hare? Impacts of within-host dynamics on transmission success of arthropod-borne viruses.

2. Size heterogeneity in the 3' noncoding region of South American isolates of yellow fever virus.

3. Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys.

4. West Nile virus (WNV) genome RNAs with up to three adjacent mutations that disrupt long distance 5'-3' cyclization sequence basepairs are viable.

5. A tetravalent dengue vaccine based on a complex adenovirus vector provides significant protection in rhesus monkeys against all four serotypes of dengue virus.

6. Substitution of wild-type yellow fever Asibi sequences for 17D vaccine sequences in ChimeriVax-dengue 4 does not enhance infection of Aedes aegypti mosquitoes.

7. Stability of yellow fever virus under recombinatory pressure as compared with chikungunya virus.

Review 8. Preclinical and clinical development of a YFV 17 D-based chimeric vaccine against West Nile virus.

9. Nonstructural Proteins Are Preferential Positive Selection Targets in Zika Virus and Related Flaviviruses.